New York State Common Retirement Fund’s LENZ Therapeutics LENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.9K Hold
5,793
﹤0.01% 3072
2026
Q1
$53K Sell
5,793
-900
-13% -$12.6K ﹤0.01% 2799
2025
Q4
$107K Buy
6,693
+2,200
+49% +$64.1K ﹤0.01% 2564
2025
Q3
$209K Sell
4,493
-2,400
-35% -$88.3K ﹤0.01% 2272
2025
Q2
$202K Buy
6,893
+3,400
+97% +$92.5K ﹤0.01% 2249
2025
Q1
$89.8K Hold
3,493
﹤0.01% 2568
2024
Q4
$101K Hold
3,493
﹤0.01% 2587
2024
Q3
$82.9K Sell
3,493
-1
-0% -$22 ﹤0.01% 2677
2024
Q2
$60.4K Buy
3,494
+4
+0.1% +$70 ﹤0.01% 3043
2024
Q1
$77.9K Sell
3,490
-1,729
-33% -$35.9K ﹤0.01% 2838
2023
Q4
$95.7K Sell
5,219
-7
-0.1% -$116 ﹤0.01% 2767
2023
Q3
$90.7K Buy
5,226
+40
+0.8% +$696 ﹤0.01% 2776
2023
Q2
$94.4K Buy
+5,186
New +$104K ﹤0.01% 2901
2022
Q3
Sell
-41
Closed -$1K 3471
2022
Q2
$1K Sell
41
-3,393
-99% -$75.6K ﹤0.01% 3425
2022
Q1
$123K Buy
3,434
+2,600
+312% +$163K ﹤0.01% 2975
2021
Q4
$73K Buy
834
+20
+2% +$1.66K ﹤0.01% 3154
2021
Q3
$93K Buy
+814
New +$121K ﹤0.01% 3164

Other funds holding LENZ

New York State Common Retirement Fund's LENZ Position: Q2 2026 in Review

New York State Common Retirement Fund held its LENZ Therapeutics (LENZ) position steady in Q2 2026 at 5,793 shares worth $32.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3072.

New York State Common Retirement Fund first reported a position in LENZ in Q3 2021 and has held it in 17 quarters since. The position peaked at $209K in Q3 2025. 23 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • New York State Common Retirement Fund held 5,793 shares of LENZ Therapeutics worth $32.9K as of Q2 2026.
  • New York State Common Retirement Fund left its LENZ Therapeutics share count unchanged in Q2 2026.
  • LENZ Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3072 holding.
  • New York State Common Retirement Fund first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 17 quarters since.
  • New York State Common Retirement Fund's LENZ Therapeutics position peaked at $209K in Q3 2025.
  • 23 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.